drugset / Trial / NCT00171613
A Study of Octreotide Depot vs Saline Control in Pediatric Hypothalamic Obesity Patients
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The extension protocol is designed to allow those patients randomized to placebo in the core portion of the protocol to receive a 6 month treatment of open label octreotide and allow those patients randomized to octreotide who appeared to benefit from treatment, to continue to receive octreotide.
Timeline
- Start
- 2005-02
- Primary completion
- 2005-10
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Octreotide | Peptide | — | — |